Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Must Maintain Oversight Role In PMI Development, Groups Urge

This article was originally published in The Pink Sheet Daily

Executive Summary

Advocates argue patient medication information documents could resemble advertising if FDA does not review and approve them before they are used, regardless of resources concerns.
Advertisement

Related Content

FDA's Chicken Or Egg Question For Pharmacy Leaflets: Should Benefit Or Risk Come First?
FDA's Chicken Or Egg Question For Pharmacy Leaflets: Should Benefit Or Risk Come First?
Assurance Vs. Flexibility: Unit-Of-Use Packaging Offers Trade-Offs For Patient Leaflets
Assurance Vs. Flexibility: Unit-Of-Use Packaging Offers Trade-Offs For Patient Leaflets
Should Rx Patient Leaflets Be Labeled Like Dietary Supplements?
Should Rx Patient Leaflets Be Labeled Like Dietary Supplements?
GDUFA Timetable Unclear, But Negotiations Will Begin With Lots Of Agreement - Except For Mylan
GDUFA Timetable Unclear, But Negotiations Will Begin With Lots Of Agreement - Except For Mylan
REMS And Benefits? FDA, Industry Debate Moving Beyond Safety Information
Single Patient Drug Leaflet Logical, Complicated To Achieve - Woodcock

Topics

Advertisement
UsernamePublicRestriction

Register

PS071236

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel